NCT00077415 2013-05-15
3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Completed
Clinical Trials
1 trialsPhase 2 × Adenocarcinoma, Bronchiolo-Alveolar × 3-aminopyridine-2-carboxaldehyde thiosemicarbazone × Clear all